1292 related articles for article (PubMed ID: 18558303)
1. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
Blair D; Byham-Gray L; Lewis E; McCaffrey S
J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
[TBL] [Abstract][Full Text] [Related]
2. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
Zisman AL; Hristova M; Ho LT; Sprague SM
Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.
Del Valle E; Negri AL; Aguirre C; Fradinger E; Zanchetta JR
Hemodial Int; 2007 Jul; 11(3):315-21. PubMed ID: 17576296
[TBL] [Abstract][Full Text] [Related]
4. Effect of high dose ergocalciferol in chronic kidney disease patients with 25-hydroxyvitamin D deficiency.
Trakarnvanich T; Chalapipat O; Disthabanchong S; Kurathong S; Praditpornsilpa K; Stitchantrakul W; Chailurkit LO
J Med Assoc Thai; 2010 Aug; 93(8):885-91. PubMed ID: 20718162
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D deficiency and associated factors in hemodialysis patients.
Jean G; Charra B; Chazot C
J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients.
Saab G; Young DO; Gincherman Y; Giles K; Norwood K; Coyne DW
Nephron Clin Pract; 2007; 105(3):c132-8. PubMed ID: 17228173
[TBL] [Abstract][Full Text] [Related]
7. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
[TBL] [Abstract][Full Text] [Related]
8. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD.
Kooienga L; Fried L; Scragg R; Kendrick J; Smits G; Chonchol M
Am J Kidney Dis; 2009 Mar; 53(3):408-16. PubMed ID: 19185400
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D status of chronic kidney disease patients living in a sunny country.
Cuppari L; Carvalho AB; Draibe SA
J Ren Nutr; 2008 Sep; 18(5):408-14. PubMed ID: 18721735
[TBL] [Abstract][Full Text] [Related]
10. Cholecalciferol supplementation in chronic kidney disease: restoration of vitamin D status and impact on parathyroid hormone.
Garcia-Lopes MG; Pillar R; Kamimura MA; Rocha LA; Canziani ME; Carvalho AB; Cuppari L
Ann Nutr Metab; 2012; 61(1):74-82. PubMed ID: 22889840
[TBL] [Abstract][Full Text] [Related]
11. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
Leventis P; Kiely PD
Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
[TBL] [Abstract][Full Text] [Related]
12. The impact of routine vitamin supplementation on serum levels of 25 (OH) D3 among the general adult population and patients with chronic kidney disease.
Tareen N; Martins D; Zadshir A; Pan D; Norris KC
Ethn Dis; 2005; 15(4 Suppl 5):S5-102-6. PubMed ID: 16315388
[TBL] [Abstract][Full Text] [Related]
13. A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.
Lindberg J; Martin KJ; González EA; Acchiardo SR; Valdin JR; Soltanek C
Clin Nephrol; 2001 Oct; 56(4):315-23. PubMed ID: 11680662
[TBL] [Abstract][Full Text] [Related]
14. The dual vitamin D pathways: considerations for adequate supplementation.
Cronin SC
Nephrol Nurs J; 2010; 37(1):19-26, 36; quiz 27-8. PubMed ID: 20333900
[TBL] [Abstract][Full Text] [Related]
15. Correction of preoperative vitamin D deficiency after Roux-en-Y gastric bypass surgery.
Nelson ML; Bolduc LM; Toder ME; Clough DM; Sullivan SS
Surg Obes Relat Dis; 2007; 3(4):434-7. PubMed ID: 17400028
[TBL] [Abstract][Full Text] [Related]
16. On-line haemodiafiltration improves response to calcifediol treatment.
Pérez-García R; Albalate M; de Sequera P; Alcázar R; Puerta M; Ortega M; Corchete E
Nefrologia; 2012 Jul; 32(4):459-66. PubMed ID: 22652556
[TBL] [Abstract][Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
[TBL] [Abstract][Full Text] [Related]
19. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
Wetmore JB; Kimber C; Mahnken JD; Stubbs JR
Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D insufficiency in a population of healthy western Canadians.
Rucker D; Allan JA; Fick GH; Hanley DA
CMAJ; 2002 Jun; 166(12):1517-24. PubMed ID: 12074117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]